REACH HIV Prevention Study in Africa (Video)

Aimed at potential study participants, this video provides background and describes the purpose and design of the Reversing the Epidemic in Africa with Choices in HIV prevention (REACH) study, or MTN-034. REACH is an open-label trial to evaluate how adolescent girls and young women use the monthly dapivirine vaginal ring and oral Truvada® (FTC/TDF) as daily pre-exposure prophylaxis (PrEP).

Length: 
7:12 minutes
Year: 
2018
Organization: 
Microbicide Trials Network
Languages: 
English